Kisspeptin: Complete Guide to the Hormone Master Switch

Kisspeptin is a neuropeptide encoded by the KISS1 gene. It was originally discovered as a metastasis suppressor (named after Hershey's Kisses — the lab was in Hershey, Pennsylvania), but its role in reproductive biology was uncovered when loss-of-function mutations in its receptor (KISS1R/GPR54) were found to cause hypogonadotropic hypogonadism — a complete failure to enter puberty.

The signaling cascade:

1. Kisspeptin neurons in the hypothalamus fire
2. Kisspeptin binds GPR54 on GnRH neurons
3. GnRH is released in pulsatile fashion
4. GnRH stimulates the pituitary to release LH and FSH
5. LH/FSH drive gonadal hormone production (testosterone, estrogen, progesterone)

Kisspeptin is literally the on switch for the entire system. It controls puberty onset, menstrual cyclicity, ovulation, and spermatogenesis.

Male Hypogonadism: Kisspeptin-54 (the full-length form) robustly stimulates LH and testosterone release in healthy men and in men with functional hypothalamic hypogonadism. Unlike exogenous testosterone (which suppresses the HPG axis), kisspeptin stimulates it — preserving fertility and natural hormone pulsatility.

Female Fertility (IVF): Professor Waljit Dhillo's group at Imperial College London has pioneered kisspeptin as an IVF trigger. In clinical trials, kisspeptin-54 successfully triggered oocyte maturation with a dramatically lower risk of ovarian hyperstimulation syndrome (OHSS) compared to hCG triggers. This is clinically significant — OHSS is a potentially life-threatening IVF complication.

Functional Hypothalamic Amenorrhea: Women who lose their periods due to stress, under-eating, or over-exercise often have suppressed kisspeptin signaling. Exogenous kisspeptin can restart the HPG axis in these cases.

Psychosexual Effects: Brain imaging studies show kisspeptin enhances limbic brain activity in response to sexual stimuli and romantic bonding cues. It may have applications in hypoactive sexual desire disorders.

vs. TRT (Testosterone Replacement): TRT provides testosterone directly but suppresses LH/FSH and spermatogenesis. Kisspeptin stimulates natural testosterone production while preserving fertility. However, kisspeptin requires a functional pituitary and gonads.

vs. Clomiphene/Enclomiphene: SERMs block estrogen feedback to increase LH/FSH. Kisspeptin acts upstream at the GnRH level. Kisspeptin may produce more physiological pulsatile GnRH release.

vs. hCG: hCG mimics LH directly at the gonadal level. Kisspeptin acts at the hypothalamic level, stimulating the entire cascade naturally. For IVF, kisspeptin appears safer (lower OHSS risk).

vs. GnRH: Continuous GnRH administration paradoxically suppresses the HPG axis (this is how Lupron works). Kisspeptin's pulsatile nature may better preserve physiological hormone patterns.

Multiple forms of kisspeptin are studied:

• Kisspeptin-54 (full-length): 6.4 nmol/kg IV bolus (acute studies) or 0.1-1.0 nmol/kg/hour IV infusion. This is the form used in most clinical trials.
• Kisspeptin-10 (C-terminal fragment): Contains the active receptor-binding sequence. More potent per mole but shorter half-life. SC dosing: 0.3-1.0 nmol/kg.

Key consideration: Like GnRH, continuous kisspeptin exposure can desensitize its receptor. Pulsatile administration (mimicking natural kisspeptin firing) may be essential for sustained HPG axis stimulation. This is an active area of research.

Kisspeptin is a paradigm shift in reproductive endocrinology. Instead of replacing hormones downstream, it restores the brain's own signaling cascade. The IVF applications are closest to clinical reality — kisspeptin triggers may become standard of care for high-OHSS-risk patients within the next few years.

For male hormone optimization, kisspeptin offers the tantalizing possibility of stimulating natural testosterone production without the fertility suppression of TRT. The main challenges are delivery (short half-life requiring frequent dosing or infusion) and the need for more long-term safety data.

This is a peptide to watch closely.